Overview

A Long-term Study of YM178 in Symptomatic Overactive Bladder Patients

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The study is intended to test the safety, tolerability, and efficacy of long-term treatment with YM178 in patients with overactive bladder symptoms.
Phase:
Phase 3
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Mirabegron